AG
TCRT icon

Advisor Group’s Alaunos Therapeutics TCRT Stock Holding History

Advisor Group’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$192K Sell
269
-3
-1% -$2.06K ﹤0.01% 2428
2019
Q3 		$174K Sell
272
-14
-5% -$11.1K ﹤0.01% 2427
2019
Q2 		$250K Buy
286
+55
+24% +$37.8K ﹤0.01% 2134
2019
Q1 		$133K Buy
231
+4
+2% +$1.67K ﹤0.01% 2611
2018
Q4 		$63K Sell
227
-43
-16% -$17K ﹤0.01% 3030
2018
Q3 		$130K Buy
270
+6
+2% +$2.57K ﹤0.01% 2549
2018
Q2 		$119K Buy
264
+107
+68% +$67.8K ﹤0.01% 2384
2018
Q1 		$92K Buy
157
+104
+196% +$64.8K ﹤0.01% 2618
2017
Q4 		$34K Sell
53
-14
-21% -$10.1K ﹤0.01% 3354
2017
Q3 		$63K Buy
67
+29
+76% +$25.8K ﹤0.01% 2767
2017
Q2 		$36K Buy
38
+2
+6% +$1.96K ﹤0.01% 3075
2017
Q1 		$35K Buy
36
+20
+125% +$18.6K ﹤0.01% 2982
2016
Q4 		$13K Sell
16
-110
-87% -$99.1K ﹤0.01% 3498
2016
Q3 		$107K Sell
126
-3
-2% -$2.41K ﹤0.01% 1956
2016
Q2 		$105K Buy
+129
New +$140K ﹤0.01% 1900

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Advisor Group's TCRT Position: Q4 2019 in Review

Advisor Group reduced its Alaunos Therapeutics (TCRT) stake by 1.1% in Q4 2019, selling an estimated $2.06K and leaving 269 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #2428.

Advisor Group first reported a position in TCRT in Q2 2016 and has held it in 15 quarters since. The position peaked at $250K in Q2 2019. 148 funds tracked by Wall St. Rank hold TCRT as of Q4 2019.

  • Advisor Group held 269 shares of Alaunos Therapeutics worth $192K as of Q4 2019.
  • Advisor Group sold 3 Alaunos Therapeutics shares in Q4 2019, an estimated $2.06K.
  • Alaunos Therapeutics made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2428 holding.
  • Advisor Group first reported a position in Alaunos Therapeutics in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Alaunos Therapeutics position peaked at $250K in Q2 2019.
  • 148 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.